Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Mortality and morbidity associated with osteoporosis drug treatment following hip fracture.

Cree MW, Juby AG, Carriere KC.

Osteoporos Int. 2003 Sep;14(9):722-7. Epub 2003 Aug 7.

PMID:
12904833
2.

Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis.

Nurmi-Lüthje I, Lüthje P, Kaukonen JP, Kataja M, Kuurne S, Naboulsi H, Karjalainen K.

Drugs Aging. 2009;26(5):409-21. doi: 10.2165/00002512-200926050-00005.

PMID:
19552493
3.
4.

Effectiveness of antiresorptive agents in the prevention of recurrent hip fractures.

Morin S, Rahme E, Behlouli H, Tenenhouse A, Goltzman D, Pilote L.

Osteoporos Int. 2007 Dec;18(12):1625-32. Epub 2007 Jul 19.

PMID:
17634854
5.

Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.

Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M, Smith DH, Platt R, Gurwitz JH.

Arch Intern Med. 2003 Sep 22;163(17):2052-7.

PMID:
14504118
6.

Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.

Perreault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandès JC.

Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):685-95.

PMID:
15645517
7.
8.

The management of osteoporosis following hip fracture: have we improved our care?

Bahl S, Coates PS, Greenspan SL.

Osteoporos Int. 2003 Nov;14(11):884-8. Epub 2003 Oct 16.

PMID:
14569422
9.

Oral bisphosphonates are associated with reduced mortality after hip fracture.

Beaupre LA, Morrish DW, Hanley DA, Maksymowych WP, Bell NR, Juby AG, Majumdar SR.

Osteoporos Int. 2011 Mar;22(3):983-91. doi: 10.1007/s00198-010-1411-2. Epub 2010 Nov 4.

PMID:
21052642
10.
11.

Treatment of postmenopausal osteoporosis.

Greenblatt D.

Pharmacotherapy. 2005 Apr;25(4):574-84. Review.

PMID:
15977918
13.

[Postmenopausal osteoporosis].

László A.

Orv Hetil. 2004 Jan 4;145(1):3-13. Review. Hungarian.

PMID:
15222134
14.

Aging bone and osteoporosis: strategies for preventing fractures in the elderly.

Ettinger MP.

Arch Intern Med. 2003 Oct 13;163(18):2237-46. Review.

PMID:
14557222
15.

Compliance with drug therapies for the treatment and prevention of osteoporosis.

McCombs JS, Thiebaud P, McLaughlin-Miley C, Shi J.

Maturitas. 2004 Jul 15;48(3):271-87.

PMID:
15207894
16.

Successful direct intervention for osteoporosis in patients with minimal trauma fractures.

Kuo I, Ong C, Simmons L, Bliuc D, Eisman J, Center J.

Osteoporos Int. 2007 Dec;18(12):1633-9. Epub 2007 Jun 30.

PMID:
17603741
17.

Hip fracture patients are not treated for osteoporosis: a call to action.

Harrington JT, Broy SB, Derosa AM, Licata AA, Shewmon DA.

Arthritis Rheum. 2002 Dec 15;47(6):651-4.

18.

Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride.

Hedlund LR, Gallagher JC.

J Bone Miner Res. 1989 Apr;4(2):223-5.

PMID:
2728925
19.

Osteoporosis: underrated, underdiagnosed and undertreated.

Nguyen TV, Center JR, Eisman JA.

Med J Aust. 2004 Mar 1;180(5 Suppl):S18-22. Review.

PMID:
14984358
20.

Health-economic comparison of three recommended drugs for the treatment of osteoporosis.

Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.

Int J Clin Pharmacol Res. 2004;24(1):1-10.

PMID:
15575171

Supplemental Content

Support Center